PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

MarketAxess Holdings_October_2020_481_61481 - MarketAxess Holdings | Presentation Nation

HomepageMarketAxess HoldingsMarketAxess Holdings_October_2020_481_61481

MarketAxess Holdings_October_2020_481_61481

MarketAxess Holdings

Browse presentations, reports, and documents from MarketAxess Holdings.

Tags

2020

Filter options

All (23)●
earnings (2)○
presentation (21)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

MarketAxess Holdings_October_2020_481_61481 by MarketAxess Holdings.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from MarketAxess Holdings

MarketAxess__2023__287_90287

presentation

MarketAxess__2023__703_95703

presentation

Similar presentations from other companies

Acorda Therapeutics_February_2020_844_51844

presentation

Acorda Therapeutics

ONE Gas_April_2020_243_54243

presentation

ONE Gas

Imperial Brands_November_2020_245_63245

MarketAxess 2Q16 Earnings Conference Call July 2016

earnings

earnings

12 Pages

MarketAxess 3Q16 Earnings Conference Call 2016

earnings

12 Pages

MarketAxess Holdings__2023__795_92795

presentation

MarketAxess Holdings_April_2018_519_25519

presentation

presentation

Imperial Brands

PitchDeck-IoT-Consulting-Partners-2021-v1.2

presentation

IoT Consulting Partners Limited

Investor-Presentation-Q22024

presentation

Vedant Fashions Limited

Intercept Pharmaceuticals_August_2020_329_59329

presentation

Intercept Pharmaceuticals